On this page
- Why measure leakage before adding locations?
- Demand, capacity and conversion: what is the difference?
- What should a portfolio measure?
- What does measuring revenue leakage in PE-backed practices involve?
- What does this look like for two practices?
- What can leakage measurement not tell you?
- How should newly acquired practices be handled?
- How does Nuvory help platforms measure this?
Key takeaways
- Revenue leakage is demand the practice already created and did not convert, so it is a natural first place to look before adding capacity.
- Measuring leakage separates operational losses from genuine capacity limits, and each calls for a different response.
- Use one definition and a baseline per practice so portfolio comparisons are fair.
- Leakage measurement informs expansion decisions; it does not predict returns or replace financial diligence.
Before a PE-backed platform adds locations or providers, it can measure how much care its existing practices already ordered, referred or recalled that never became completed visits and procedures. Measured on one definition across the portfolio, that revenue leakage shows where existing demand is being lost, which practices have operational room to grow, and where new capacity is genuinely needed. It informs the expansion decision. It does not, on its own, predict a return.
This kind of leakage is rarely measured, because care that never happened never appears in standard financial reports.
Why measure leakage before adding locations?
Because a new location adds capacity, and capacity only helps if demand is being turned away for lack of it.
Most growth plans for specialty platforms lean on a familiar set of levers: recruit providers, open sites, add ancillaries, improve payer contracts. Those levers are sound. But every specialty practice also carries demand it already created and did not convert: referred patients never seen, procedures ordered and never scheduled, surveillance patients past due. That demand costs nothing to acquire. It was earned by the practice's own providers and referral relationships.
The order of operations matters. If a practice loses referred patients because nobody calls them within a reasonable time, opening a second site copies the same process to a new address. If it loses them because the next available appointment is months away, that is a capacity signal, and expansion may be exactly right. Leakage measurement is how you tell those two situations apart.
Demand, capacity and conversion: what is the difference?
| Question | What it measures | Where the answer usually lives |
|---|---|---|
| Is there demand? | Referrals received, orders placed, recalls due | EHR orders, referrals and recall data |
| Is there capacity? | Open slots, days to next available, provider time | The schedule and templates |
| Is demand converting? | Share of demand that becomes completed care, and how long it takes | Matching orders and referrals to completed encounters and procedures |
Growth planning often checks the first two and assumes the third. Conversion is where leakage lives.
What should a portfolio measure?
Keep the list short and consistent. Each measure below answers a specific question relevant to an expansion decision.
| Measure | What it tells a growth plan |
|---|---|
| Referral-to-visit conversion | Whether earned referrals become patients, or stall before the first visit |
| Time to first contact on referrals | Whether stalls are operational (slow response) rather than capacity-driven |
| Procedure orders open past their window, by age | How much ordered procedure volume is still waiting |
| Canceled procedures rebooked | Whether lost slots are recovered or quietly lost |
| Recall completion | Follow-through on surveillance and chronic care |
| Days to next available, by service | Whether capacity is the real constraint |
| Estimated open value | The rough size of unconverted demand, labeled as an estimate |
The revenue leakage metrics guide explains how to calculate and read most of these.
What does measuring revenue leakage in PE-backed practices involve?
Measuring revenue leakage across PE-backed practices involves five steps: agree one definition per leakage type, connect and baseline each practice under those definitions, validate the rules with clinicians, record why items stall, then work ranked lists for a defined period and compare completion against baseline before revisiting expansion plans.
Agree definitions first
Each acquired practice arrives with its own idea of when a referral is closed or an order is overdue. Agree one definition per leakage type, covering what opens an item, what closes it and what is excluded, before comparing anyone. Let practices vary windows and code mappings, not the logic. The MSO revenue leakage definitions guide includes a definition table you can adapt.
Connect and baseline each practice
Each practice needs its EHR administrator's approval and a business associate agreement in place before any patient data is read. Then restate its history under the shared definitions to build a baseline. A practice that joined last month and one that joined three years ago both get their own starting point.
Validate with clinicians
Clinical reviewers approve the rules and windows, and staff spot-check a sample of flagged patients against the chart. A portfolio number built on unvalidated rules will not survive its first review with a medical director.
Record why items stall
Separate stall reasons into operational causes (no contact, no follow-up after a voicemail, authorization not chased) and capacity causes (no slot within a reasonable time, provider templates full). This is the step that turns a leakage number into a growth insight.
Work the lists, then decide
Give local teams ranked lists for a defined period and compare completion against baseline. Only then revisit expansion plans for each market.
What does this look like for two practices?
Illustrative example. A platform is weighing a second site in two markets. Both practices show a similar volume of referred patients who were never seen.
At Practice A, most stalled referrals were never contacted within the window, and the schedule shows open new-patient slots most weeks. The leakage is operational. A ranked list and clear ownership are likely to recover some of it, and a new site would inherit the same follow-through problem.
At Practice B, referrals are contacted promptly, but the next available procedure slot is far out, and a meaningful number of patients appear to have gone elsewhere for care. The leakage is capacity-driven, and the case for added capacity is stronger. Understanding where those patients went is its own exercise, covered in how to measure network leakage.
Same headline number, opposite conclusions. The inputs are hypothetical and chosen only to show the reasoning.
What can leakage measurement not tell you?
Be precise about the limits, especially in board materials.
- It does not predict returns. Estimated open value is an estimate of care not yet delivered, not a forecast of collections.
- It does not prove cause. Care completed after detection, compared with a baseline, shows correlation with outreach. Some patients would have returned anyway.
- It does not judge clinical appropriateness. Whether a patient still needs a test or procedure is a clinician's decision.
- It does not capture patient choice. Some patients decline care, move or change insurers.
- It does not replace financial diligence. Payer mix, reimbursement and market dynamics still need their own analysis.
How should newly acquired practices be handled?
Give each new practice its own baseline before its numbers enter any portfolio comparison. Practices often keep their own EHR for some time, so confirm what each system's data can support. Any use of patient-level data before close depends on the practice's own agreement, a BAA and its EHR administrator's approval; the natural fit is after close, during integration. A revenue leakage assessment is a practical first exercise for a newly joined practice.
How does Nuvory help platforms measure this?
Nuvory reads each practice's EHR nightly, applies one set of rules signed off by clinical reviewers, builds a baseline per practice from about two years of history, and gives local staff ranked lists. It reports care completed after detection against baseline, as correlation rather than proof of cause, and it does not promise financial returns. See revenue leakage intelligence for PE-backed practices and more in revenue leakage.
Portfolio leakage measurement checklist
- Agree shared leakage definitions before comparing any practices
- Confirm EHR access, a BAA and administrator approval for each practice
- Build a baseline per practice under the shared definitions
- Have clinical reviewers approve the rules and windows
- Record why items stall so operational and capacity causes can be separated
- Check days to next available appointment for the services that leak most
- Work the lists for a defined period and compare with baseline
- Revisit expansion plans with the leakage and capacity findings in hand
Frequently asked questions
Is revenue leakage the same as same-store growth?
Not exactly. Same-store growth is a financial outcome at existing locations. Revenue leakage is one operational source of it: demand the practice already created that did not become completed care. Recovering some of that leakage can contribute to same-store growth, alongside pricing, payer and staffing factors.
Can leakage data be used during diligence?
Only with the target practice's agreement, a business associate agreement and its EHR administrator's approval. Without those, patient-level data should not be reviewed. The more common use is after close, to set a baseline for each practice during integration.
Should a platform pause expansion until leakage is measured?
Not necessarily. Measurement can run alongside planning. The point is to have conversion and capacity data in hand before committing to a new site, so the decision reflects whether demand is being lost to process or to a real lack of capacity.
How should leakage appear in board reporting?
As estimated open value and completion trends against each practice's baseline, clearly labeled as estimates and correlation. Avoid presenting recovered value as caused by any one initiative, and keep it separate from financial forecasts.